Can Game-Based Digital Therapeutics Help Children with ADHD? (2025 Review)

Target: Children with ADHD aged 8–17 Type: Other (Narrative Review) Grade: C

3-Line Summary

What: This review comprehensively summarized the clinical evidence and regulatory status of pediatric digital therapeutics (e.g., EndeavorRx).
Who: Children aged 8–17 with ADHD who participated in game-based attention training RCTs.
Result: Attention test performance improved, but the effect size was moderate, and it is recommended as a complementary option to existing treatments.

Keywords

digital therapeutics EndeavorRx FDA-approved game-based attention training

Practical Tips

FDA-approved digital therapeutics (EndeavorRx) are classified as medical devices and require a specialist consultation before use.
Note that general educational game apps are different from FDA-approved digital therapeutics.
Digital therapeutics are recommended as a supplement to existing treatments (medication, behavioral therapy).